We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-8.62%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$902M
AUM Growth
-$613M
Cap. Flow
-$411M
Cap. Flow %
-45.55%
Top 10 Hldgs %
57.67%
Holding
342
New
42
Increased
40
Reduced
54
Closed
115

Top Buys

Rank Stock Value
1
AMRX icon
Amneal Pharmaceuticals
AMRX
+$6.87M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$3.2M
3
TSM icon
TSMC
TSM
+$1.88M
4
BKNG icon
Booking.com
BKNG
+$1.49M
5
WPM icon
Wheaton Precious Metals
WPM
+$1.48M

Top Sells

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$33.8M
2
ARRY
Array Biopharma Inc
ARRY
+$23.1M
3
INCY icon
Incyte
INCY
+$10.1M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$9.75M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$9.33M

Sector Composition

Rank Sector Weight
1 Healthcare 16.66%
2 Industrials 5.91%
3 Financials 5.49%
4 Technology 5.04%
5 Communication Services 3.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
226
Bank of America
BAC
$433B
– –
-8,000
Closed -$226K
BLRX
227
BioLineRX
BLRX
$11.7M
– –
-1,217
Closed -$263K
BMY icon
228
Bristol-Myers Squibb
BMY
$132B
– –
-83,000
Closed -$3.74M
CDTX
229
DELISTED
Cidara Therapeutics
CDTX
– –
-15,334
Closed -$481K
CERS icon
230
Cerus
CERS
$579M
– –
-669,245
Closed -$3.31M
CHKP icon
231
Check Point Software Technologies
CHKP
$13.1B
– –
-1,800
Closed -$207K
CHRS icon
232
Coherus Oncology
CHRS
$227M
– –
-238,248
Closed -$5.12M
COST icon
233
Costco
COST
$423B
– –
-1,000
Closed -$266K
CRIS icon
234
Curis
CRIS
$9.67M
– –
-1,455
Closed -$1.06M
CRVS icon
235
Corvus Pharmaceuticals
CRVS
$1.11B
– –
-184,116
Closed -$624K
CTMX icon
236
CytomX Therapeutics
CTMX
$714M
– –
-97,457
Closed -$1.03M
CYTK icon
237
Cytokinetics
CYTK
$10.9B
– –
-148,353
Closed -$1.64M
DBRG icon
238
DigitalBridge
DBRG
$2.93B
– –
-1,692,324
Closed -$33.8M
EMR icon
239
Emerson Electric
EMR
$83.3B
– –
-3,470
Closed -$229K
FOLD
240
DELISTED
Amicus Therapeutics
FOLD
– –
-741,969
Closed -$8.9M
HRTX icon
241
Heron Therapeutics
HRTX
$94.1M
– –
-171,557
Closed -$3.16M
INCY icon
242
Incyte
INCY
$24.9B
– –
-119,310
Closed -$10.1M
IOVA icon
243
Iovance Biotherapeutics
IOVA
$2.09B
– –
-413,154
Closed -$9.33M
IRWD icon
244
Ironwood Pharmaceuticals
IRWD
$614M
– –
-439,853
Closed -$4.75M
KALA icon
245
KALA BIO
KALA
$13.6M
– –
-99
Closed -$1.45M
KURA icon
246
Kura Oncology
KURA
$826M
– –
-370,958
Closed -$7.34M
LXRX icon
247
Lexicon Pharmaceuticals
LXRX
$1.04B
– –
-181,000
Closed -$1.1M
MCK icon
248
McKesson
MCK
$101B
– –
-7,985
Closed -$1.07M
LITS
249
Lite Strategy Inc
LITS
$33.6M
– –
-19,826
Closed -$995K
MGNX icon
250
MacroGenics
MGNX
$240M
– –
-131,573
Closed -$2.19M
8 9
10
11 12

Similar funds

NC
NovaPoint Capital Atlanta, Georgia $399M AUM 26.97% 1-Year Est. Return
T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return
THL
Tillman Hartley LLC Denver, Colorado $398M AUM 16.44% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BWM
BCGM Wealth Management Lafayette, Indiana $398M AUM 17.85% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return

Fosun International's Q3 2019 Portfolio in Review

As of Q3 2019, Fosun International held 342 positions worth $902M, down 40% from $1.51B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Fosun International withdrew a net $411M in Q3 2019, closing 115 positions and reducing 54 holdings. Its most notable exit was DigitalBridge, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 32% a quarter earlier, followed by Industrials and Financials.

Against the trend, Fosun International opened a new position in Zoetis worth $1.24M.

  • Fosun International's largest Q3 2019 buy was Zoetis: 10,000 shares worth $1.24M.
  • Fosun International added most to Amneal Pharmaceuticals in Q3 2019, an estimated $6.87M increase.
  • Fosun International's biggest Q3 2019 reduction was BioMarin Pharmaceuticals, cutting an estimated $7.14M.
  • Fosun International fully exited DigitalBridge in Q3 2019, selling an estimated $33.8M.
  • Fosun International's ten largest holdings make up 58% of its $902M portfolio in Q3 2019.
  • Fosun International opened 42 new positions and closed 115 in Q3 2019.
  • Fosun International's portfolio value fell 40% quarter-over-quarter to $902M.

Based on Fosun International's 13F filing for Q3 2019, filed 12 Nov 2019.